AvroBio Inc

Research AvroBio Inc (TECX) on Bullrun: market cap USD 624.38M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTECX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 624.38M
• Financial periodFY2025
• Net income-USD 74.15B
• Free cash flow-USD 60.29M

Valuation Snapshot

latest market cap is USD 624.38M.

About AvroBio Inc

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin.

Frequently asked questions

What is AvroBio Inc's market cap?

AvroBio Inc's market capitalization is USD 624.38M.

What does AvroBio Inc do?

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs).